Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current revenue (TTM ) is ยฃ9.63 Billion. a decrease over the revenue in the year 2023 that were of ยฃ10.75 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | ยฃ10.24 B | -4.76% |
2023 | ยฃ10.75 B | -12.05% |
2022 | ยฃ12.23 B | 29.14% |
2021 | ยฃ9.47 B | 10.59% |
2020 | ยฃ8.56 B | -1.16% |
2019 | ยฃ8.66 B | -1.1% |
2018 | ยฃ8.76 B | 12.12% |
2017 | ยฃ7.81 B | -5.13% |
2016 | ยฃ8.23 B | 22.45% |
2015 | ยฃ6.72 B | -31.03% |
2014 | ยฃ9.75 B | 5.86% |
2013 | ยฃ9.21 B | 4.93% |
2012 | ยฃ8.77 B | -1.78% |
2011 | ยฃ8.93 B | 7.44% |
2010 | ยฃ8.31 B | 7.17% |
2009 | ยฃ7.76 B | -7.86% |
2008 | ยฃ8.42 B | 48.61% |
2007 | ยฃ5.66 B | 7.01% |
2006 | ยฃ5.29 B | -7.23% |
2005 | ยฃ5.71 B | 15.31% |
2004 | ยฃ4.95 B | -0.61% |
2003 | ยฃ4.98 B | -0.55% |
2002 | ยฃ5.01 B | -5.18% |
2001 | ยฃ5.28 B | 14.39% |
2000 | ยฃ4.62 B | 17.02% |
1999 | ยฃ3.94 B | 6.76% |
1998 | ยฃ3.69 B | -1.02% |
1997 | ยฃ3.73 B | 17.65% |
1996 | ยฃ3.17 B |